CARDOZA GEORGE

CIK 00015187342 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001518734

Recent Transactions

50 trades

Sale
SOPHiA GENETICS SA$SOPH
Ordinary Shares
2026-03-19$4.79/sh−774→ 184,858 total
Tax Payment
NEOGENOMICS INC$NEO
Common Stock
2022-03-02−839→ 244,157 total
Tax Payment
NEOGENOMICS INC$NEO
Common Stock
2022-03-01−503→ 244,996 total
Award
NEOGENOMICS INC$NEO
Common Stock
2021-12-30+61,143→ 245,499 total
Award
NEOGENOMICS INC$NEO
Common Stock
2021-07-05+7,584→ 184,356 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2021-07-05$43.95/sh+40,502→ 40,502 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2021-06-03$40.11/sh−31,107→ 176,772 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2021-06-02$40.39/sh−169,230→ 207,879 total
Award
NEOGENOMICS INC$NEO
Common Stock
2021-03-02+6,207→ 377,109 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2021-03-02$53.17/sh+35,171→ 35,171 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2020-11-25$7.52/sh+77,074→ 447,976 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2020-11-25−77,074→ 50,000 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2020-11-25$45.48/sh−77,074→ 370,902 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2020-11-24$7.52/sh+72,926→ 423,828 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2020-11-24$45.19/sh−52,926→ 370,902 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2020-11-24−72,926→ 127,074 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2020-08-06$39.35/sh−82,500→ 350,902 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2020-08-06$7.15/sh+100,000→ 433,402 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2020-08-06−100,000→ 0 total
Award
NEOGENOMICS INC$NEO
Common Stock
2020-03-02+7,571→ 333,402 total
Award
NEOGENOMICS INC$NEO
Common Stock
2020-03-02$28.33/sh+48,768→ 48,768 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2019-11-12$7.15/sh+44,444→ 345,275 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2019-11-12$23.15/sh−19,444→ 325,831 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2019-11-12−44,444→ 100,000 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2019-11-07$22.80/sh−4,000→ 300,831 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2019-11-06$22.82/sh−51,556→ 304,831 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2019-11-06$7.15/sh+55,556→ 356,387 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2019-11-06−55,556→ 144,444 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2019-05-03$22.82/sh−151,676→ 300,831 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2019-05-02−200,000→ 0 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2019-05-02$4.78/sh+200,000→ 452,507 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2019-03-01$19.60/sh+51,459→ 51,459 total
Award
NEOGENOMICS INC$NEO
Common Stock
2019-03-01+8,418→ 252,507 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2019-02-27$3.45/sh+30,000→ 244,089 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2019-02-27$3.45/sh−30,000→ 0 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Restricted Stock
2018-05-25−8,333→ 16,667 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2018-05-25+8,333→ 197,422 total
Award
NEOGENOMICS INC$NEO
Stock Options (Right to Buy)
2018-02-26$8.03/sh+192,500→ 192,500 total
Award
NEOGENOMICS INC$NEO
Restricted Stock
2017-05-25+25,000→ 25,000 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2017-04-28$7.52/sh+200,000→ 200,000 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2016-04-20$7.15/sh+200,000→ 200,000 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2016-03-11$6.83/sh−32,000→ 189,089 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2016-03-11$1.46/sh+100,000→ 221,089 total
Exercise of In-Money
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2016-03-11$1.46/sh−100,000→ 0 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2015-05-04$4.78/sh+200,000→ 200,000 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2014-11-26$1.55/sh+130,000→ 181,089 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2014-11-26$4.28/sh−60,000→ 121,089 total
Exercise of In-Money
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2014-11-26$1.55/sh+130,000→ 0 total
Award
NEOGENOMICS INC$NEO
Common Stock
2013-12-09$1.55/sh+20,000→ 71,089 total
Sale
NEOGENOMICS INC$NEO
Common Stock
2013-12-09$3.66/sh−20,000→ 51,089 total

Companies

Recent Filings

Address

C/O SOPHIA GENETICS INC. 401 PARK DRIVE, FLOOR 5

BOSTON, MA, 02215

View on SEC.gov